Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model

被引：28

作者：

Hadad, Sirwan M. ^{[1
]}

Appleyard, Virginia ^{[1
]}

Thompson, Alastair M. ^{[1
]}

机构：

[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, Dundee DD1 9SY, Scotland

来源：

BREAST CANCER RESEARCH AND TREATMENT | 2009年 / 114卷 / 02期

关键词：

CELL LINES;

D O I：

10.1007/s10549-008-0016-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：391 / 391

页数：1

共 6 条

[1]

BRINKLEY BR, 1980, CANCER RES, V40, P3118

[2]

CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911

[3] Further evidence to support the melanocytic origin of MDA-MB-435 [J].

Ellison, G ;

Klinowska, T ;

Westwood, RFR ;

Docter, E ;

French, T ;

Fox, JC .

JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2002, 55 (05) :294-299

[4] Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model [J].

Phoenix, Kathryn N. ;

Vumbaca, Frank ;

Claffey, Kevin P. .

BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (01) :101-111

[5] MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research [J].

Rae, James M. ;

Creighton, Chad J. ;

Meck, Jeanne M. ;

Haddad, Bassem R. ;

Johnson, Michael D. .

BREAST CANCER RESEARCH AND TREATMENT, 2007, 104 (01) :13-19

[6] Systematic variation in gene expression patterns in human cancer cell lines [J].

Ross, DT ;

Scherf, U ;

Eisen, MB ;

Perou, CM ;

Rees, C ;

Spellman, P ;

Iyer, V ;

Jeffrey, SS ;

Van de Rijn, M ;

Waltham, M ;

Pergamenschikov, A ;

Lee, JCE ;

Lashkari, D ;

Shalon, D ;

Myers, TG ;

Weinstein, JN ;

Botstein, D ;

Brown, PO .

NATURE GENETICS, 2000, 24 (03) :227-235

← 1 →